KC
Highly rated in
23
conditions
Highly rated in
23
conditions
Check Dr. Karim Chamie's experience treating your condition:
About Dr. Karim Chamie

Karim Chamie is an Urologist and a Surgical Oncologist in Los Angeles, California. Chamie has been practicing medicine for over 19 years and is highly rated in 23 conditions, according to our data. His top areas of expertise are Bladder Cancer, Urothelial Cancer, Renal Cell Carcinoma RCC, and Prostate Cancer. He is licensed to treat patients in California. Chamie is currently accepting new patients.

His clinical research consists of co-authoring 126 peer reviewed articles and participating in 3 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Karim Chamie it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Karim Chamie accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
200 Medical Plz Dr Way, Suite 140, Los Angeles, CA 90095
Other Locations
200 Medical Plz Dr Way, Suite 140, Los Angeles, CA 90095
Background & Education
Graduate Institution
Other, 2003.0
Specialties
Urology
Surgical Oncology
Licenses
Surgery in CA
Hospital Affiliations
UCLA Health - Santa Monica Medical Center
Ronald Reagan UCLA Medical Center
Olive View - UCLA Medical Center
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


3 Clinical Trials

A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
126 Total Publications

Quality-of-Life Outcomes and Toxicity Profile Among Patients with Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multi-Center Phase 2 Trial.
Summary: Quality-of-Life Outcomes and Toxicity Profile Among Patients with Localized Prostate Cancer After Radical Prostatectomy Treated With Stereotactic Body Radiation: The SCIMITAR Multi-Center Phase 2 Trial.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors